IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Opportunity Management V, LLC

Q1 2022 Holdings

Filed 2022-05-13 | 10 holdings | $9.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cue Health Inc.(HLTHQ)COM229790100$4.1M641,48345.1%
Cullinan Oncology, Inc.(CGEM)COM230031106$3.5M330,83637.8%
Compass Therapeutics, Inc.(CMPX)COM20454B104$1.5M1,100,00016.4%
Pardes Biosciences IncCOM69945Q105$37.7K5,227,3070.4%
Quantum-Si Incorporated(QSI)COM CL A74765K105$7.5K1,598,1250.1%
Theseus Pharmaceuticals, Inc.COM88369M101$5.4K468,8200.1%
Adicet Bio, Inc.(TORCEUR)COM007002108$3.4K170,0000.0%
Gemini Therapeutics, Inc.COM36870G105$3.4K2,435,1250.0%
Kinnate Biopharma Inc.COM49705R105$3.3K291,6670.0%
Enanta Pharmaceuticals, Inc.(ENTA)COM29251M106$1.6K22,7500.0%